Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-22

FDA Approved: BIVALIRUDIN — Original Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved Accord Healthcare's generic version of bivalirudin, expanding access to the anticoagulant used to prevent clotting during procedures such as percut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bivalirudin (bivalirudin)

Snippet

ORIG AP for BIVALIRUDIN (BIVALIRUDIN)